EverHint Signal — EMA10 × Price × MACD — November 20, 2025

November 20, 2025

What This Signal Is (Quick)

This experimental scanner looks for a double bullish confirmation firing on the same day: price reclaiming the short-term trend and momentum flipping positive.

Specifically, a stock makes the list when:

1. Price crosses above EMA10 from below
   • Yesterday: price was at or below the 10-day EMA
   • Today: price closes above the 10-day EMA
   • This flags a short-term trend break in favor of the bulls.
2. MACD Line crosses above Signal Line from below
   • Yesterday: MACD Line at or below the Signal Line
   • Today: MACD Line moves above the Signal Line
   • This confirms an underlying momentum shift, not just a one-day bounce.

Only when both crossovers happen together do we log a buy-side event for that date. No sell signals are produced by this particular scanner. It’s tuned for swing trading horizons of roughly 1–4 weeks and will tend to produce fewer but higher-conviction candidates compared with single-indicator systems.

This is an experimental signal, intended for research, back-testing, and idea generation—not as a standalone trading system.

How We Ranked Today (Reader Version)

Today’s report covers 7 symbols flagged on November 20, 2025.

Because no specific ranking override was given, the list is ordered by:

• Primary:
  • RSI(14) (highest first) — stronger short-term momentum gets a better rank.
• Overlays (context, not strict sort keys):
  • Insider Net (USD, 90 days) — net open-market buying vs. selling (P vs. S only).
  • Days → Earnings — proximity to the next earnings event.
  • Analyst coverage & consensus — number of estimates and how tight the EPS range is (used in commentary).

Think of this as:

“RSI-driven momentum list, annotated with insider flows and event risk.”

Signals are for educational use and back-testing, not trade recommendations.

📈 Buy-Side Signals — EMA10 × Price × MACD (Ranked by RSI)

All entries below fired same-day price + MACD bullish crossovers on November 20, 2025.

Ranked Signals Table

Field notes on the table:

• Last ($): closing price on the signal date.
• RSI(14):
  • ~70 (WMT) → strong momentum, edging toward overbought territory.
  • 50–60 (ESS, SLGN) → constructive, trending higher but not stretched.
  • 30–45 (BCC, QGEN, NOC, ODD) → early-stage recoveries or more choppy profiles.
• Insider Net (USD, 90d):
  • Positive (e.g., SLGN ≈ +$0.27M) → net open-market buying.
  • Negative (WMT ≈ -$115M) → sizable net selling by insiders.
  • “—” → no meaningful P/S transactions in the last 90 days based on the current data.
• Days → Earnings:
  • 0 (today) — earnings event on the same day as the signal (WMT).
  • 70–76 days — NOC, ESS, QGEN, SLGN have earnings out in late Jan / early Feb 2026.
  • “—” — no upcoming earnings in the current calendar snapshot (BCC, ODD).

Recent Headlines Around Today’s Signals

This section gives context, not a scoring impact.

WMT — Walmart Inc. (rank 1, RSI ≈ 70.5)

• Walmart reported another strong quarter, with mid-single-digit revenue growth and e-commerce expanding north of 20%, prompting management to raise full-year sales and EPS guidance. (Reuters)
• The company also announced a listing move from NYSE to Nasdaq in December, a high-profile exchange switch aligned with its positioning as a tech- and automation-driven retailer. (Financial Times)

Read-through:
Price-wise, WMT sits at the top of today’s RSI ranking, and the EMA10 × Price × MACD trigger comes on the back of solid fundamental news. The red flag is heavy net insider selling (~$115M over 90 days), which may simply reflect profit-taking after a strong run rather than a fundamental crack.

ESS — Essex Property Trust, Inc. (rank 2)

• No fresh company-specific news in the file today, but ESS represents coastal multifamily real estate, a rate-sensitive pocket that often trades as a defensive income play when macro risk rises.
• Analyst consensus for the nearest year shows tight EPS bands with around half a dozen analysts, hinting at relatively stable expectations rather than a high-uncertainty story (based on the current estimates snapshot).

SLGN — Silgan Holdings Inc. (rank 3)

• SLGN shows a moderate RSI in the high-40s with a bullish crossover, plus modest net insider buying (~$0.27M) over the last 90 days.
• The earnings calendar puts the next report roughly 76 days out, which means no near-term event overhang, giving the technical pattern more room to play out without immediate earnings headline risk.

BCC — Boise Cascade Company (rank 4)

• Headlines show a mix of sentiment:
  • One Zacks piece grouped BCC among “new strong sell” ideas, reflecting cautious or valuation-driven views from their style model.
  • Separately, Boise Cascade announced an agreement to purchase Homeco, signaling ongoing strategic M&A activity in building products and distribution.
• Analyst estimates around the 2025 fiscal year show mid-single-digit EPS expectations with a fairly tight range, implying moderate but not explosive growth.

QGEN — Qiagen N.V. (rank 5)

• Recent headlines highlight:
  • Qiagen presenting at Jefferies London Healthcare and Wolfe Research conferences, keeping the story in front of institutional investors.
  • A co-marketing tie-up with CellBxHealth to push a precision oncology platform, positioning QGEN further into the diagnostics / precision medicine narrative.
  • Analyst commentary noting international revenue mix as a key swing factor for growth.

Together this paints QGEN as a steady diagnostics name with ongoing partnership news flow, now showing a fresh EMA10 × Price × MACD bullish inflection.

NOC — Northrop Grumman Corporation (rank 6)

• No specific news in the provided feed today, but NOC typically trades as a large-cap defense bellwether.
• Analyst estimates for the closest fiscal year cluster around mid-20s EPS, with several analysts contributing, which is consistent with a well-covered, mature defense franchise.

ODD — Oddity Tech Ltd. (rank 7)

• No fresh news in the feed for today’s run.
• As a tech/consumer-facing name, ODD sits at the bottom of our RSI-ranked list (low-30s), but still triggered the double crossover. That profile often points to a possible early-stage turnaround rather than an extended uptrend.

📉 Sell-Side Signals

This particular EMA10 × Price × MACD configuration is currently buy-only, so there are no sell-side signals to report for November 20, 2025.

Field Notes

1. How to read RSI(14):

• 70+ – Strong momentum; often “extended,” but powerful trends can stay elevated.
• 50–70 – Constructive uptrends; dips can be buyable in robust markets.
• 30–50 – Early recovery or range-bound; much more path-dependent.
• <30 – Oversold; can signal exhaustion, but also where downtrends live.

In today’s list:

• WMT is the only true momentum standout with RSI just above 70.
• The cluster (ESS, SLGN, BCC, QGEN) in the 40–56 band looks more like grinding uptrends or post-pullback recoveries than runaway momentum.
• NOC and ODD sit in the low- to mid-30s, suggesting “early reversal” or “still fragile” setups.

2. Insider flows:

• WMT: sizable net selling (~$115M), likely a function of long-term share price strength and liquidity. It doesn’t invalidate the signal but argues for more conservative sizing if trading it.
• SLGN: modest net buying (~$0.27M) from insiders—that’s supportive, but not large enough on its own to be a decisive factor.
• Others: no notable open-market P/S activity recorded in the 90-day window.

3. Earnings timing:

• WMT: earnings today – that’s a classic “post-earnings technical flip”.
• ESS, NOC, QGEN, SLGN: earnings clustered 70–76 days out → moderate runway before the next major event.
• BCC, ODD: no date in the current earnings snapshot.

For swing traders, entries taken within a week of earnings demand tighter risk controls; the rest of the list has more breathing room.

4. Analyst lens (quick take):

From the nearest-year estimates snapshot:

• WMT: dense coverage (≈20+ EPS estimates) with a relatively narrow range — classic large-cap, high-visibility profile.
• ESS / SLGN / BCC / QGEN / NOC: each show multiple analysts and fairly tight EPS bands, consistent with stable, well-followed names rather than speculative microcaps.
• Overall, this scan leaned into liquid, institutionally-owned tickers, which matches its liquidity filter design.

Vlad’s Take (EverHint)

Today’s backdrop was decidedly risk-off:

• The S&P 500 fell about 3%, the Nasdaq dropped more than 4%, and the Dow lost roughly 1.6%, with small caps (Russell 2000) down about 2.4%.
• The VIX jumped into the mid-20s (≈26.4), a clear sign of elevated fear rather than a calm tape.
• Bitcoin and Ethereum slid ~4½–5%, underscoring broad risk-asset de-risking, even in crypto.
• The 10-year Treasury yield eased slightly to ~4.10%, a mild tailwind for rate-sensitive assets even as equities sold off.

All of this unfolded as investors wrestled with AI-bubble concerns and a sharp reversal in big-tech leadership after initially strong Nvidia-driven enthusiasm. (The Guardian)

Against that macro backdrop:

• It’s not surprising that the scanner surfaced:
  • A defensive retail giant (WMT),
  • A multifamily REIT (ESS),
  • A packaging name (SLGN),
  • Plus defense, healthcare, and materials (NOC, QGEN, BCC) rather than a basket of high-beta, speculative tech.
• The signals are interesting precisely because they fired into a sell-off, not after the fact. That’s often where some of the best swing entries hide—but also where false positives spike.

How to think about it, from a risk-management perspective:

• Tiered entries (scale in vs. all-at-once) make sense when the VIX lives in the mid-20s.
• Consider shorter holding horizons and tighter stops than you might use in a low-volatility grind-up tape.
• Pay particular attention to:
  • WMT’s post-earnings behavior over the next few sessions (does the breakout hold above EMA10?), and
  • Whether ESS / SLGN / QGEN show follow-through with rising volume rather than fading back below their short-term trend.

As always, treat this as one lens among many. The EMA10 × Price × MACD signal is a tool for structuring watchlists and back-tests, not a complete trading plan on its own.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.